Keywords: tariquidar, trial, suspension, hits, xenova, shares, hard

Tariquidar trial suspension hits Xenova shares hard; overreaction, says UK firm

Article | 03 March 2003

Print This

UK biotechnology company Xenova saw its shares hit a five-year low onFebruary 21, after reporting that patient enrollment into its Phase ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in